http://www.acc.org/Feed?clinicalTopicID=5f25c4ac-b76f-4970-a93c-15cdf264bed5 Clinical Topic Feed: Dyslipidemia en /Latest-in-Cardiology/Articles/2026/10/13/14/51/accel-lite-13oct2026 In this episode, Allen J. Taylor, MD, FACC and Joseph Brent Muhlestein, MD, FACC discuss “CorCal: Pooled Cohort Equations versus Coronary Artery Calcium Score in ASCVD Primary Prevention”. 1791906300000 Articles and Stories /Latest-in-Cardiology/Articles/2026/10/09/15/06/AMUNDSEN Lipid lowering after acute myocardial infarction (MI) is central to secondary prevention, but stepwise therapy may delay LDL-C target attainment. The AMUNDSEN trial, presented at ESC Congress 2026 and simultaneously published in JAMA, assessed whether pre-PCI evolocumab could accelerate LDL-C reduction and improve clinical outcomes. 1791903300000 Articles and Stories /Latest-in-Cardiology/Articles/2026/10/01/01/Feature-ESC-Congress-2026 The ACC was live from ESC Congress 2026 in Munich, bringing members the latest cardiovascular science and clinical guidance. Below are standout studies in heart failure (HF), structural heart disease, dyslipidemia and prevention, and more, plus promising news in pulmonary embolism (PE). 1790857080000 Articles and Stories /Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career! 1790848980000 Articles and Stories /Latest-in-Cardiology/Articles/2026/09/29/11/11/Statins-For-the-Prevention-of-Anthracycline-Induced-Cardiotoxicity Anthracycline-induced cardiotoxicity is a major contributor to long-term cardiovascular (CV) outcomes in survivors of cancer. Up to 20% of patients exposed to anthracyclines develop irreversible cardiomyopathy through mechanisms leading to cardiomyocyte death. 1790695860000 Articles and Stories /Latest-in-Cardiology/Articles/2026/09/28/16/16/cardiacast_28sep2026 This episode is part of ACC’s ongoing initiative on implementing the 2026 Dyslipidemia guidelines. 1790612400000 Articles and Stories /Latest-in-Cardiology/Articles/2026/09/25/14/46/cardiacast_25sep2026 This episode is part of ACC’s ongoing initiative to recognize the risks and tackle management of hypertriglyceridemia (HTG) and severe hypertriglyceridemia (sHTG). 1790352000000 Articles and Stories /Latest-in-Cardiology/Articles/2026/09/21/17/24/Beyond-the-Tumor ASCVD prevention has historically targeted the general adult population, with survivors of cancer and patients with active cancer being underrepresented. Cancer and its therapies may increase cardiovascular (CV) risk and accelerate vascular disease through treatment-related dyslipidemia... 1790093640000 Articles and Stories /Education-and-Meetings/Patient-Case-Quizzes/2026/09/22/14/57/Management-of-Severe-Hypertriglyceridemia A 62-year-old man with coronary artery disease with a single coronary stent from 10 years ago presents for follow-up. His other medical history includes former smoking and hypertension, which is currently well managed. 1790089200000 Educational Activities /Latest-in-Cardiology/Articles/2026/09/21/17/24/Beyond-Calcium South Asian (SA) individuals experience a disproportionate burden of premature atherosclerotic cardiovascular disease (ASCVD), and this excess risk is not fully explained by traditional risk factors. 1790016900000 Articles and Stories